Waddell & Reed Financial’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Waddell & Reed Financial’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-278,825	Closed	-$21M	–	688
2015 Q2	$21M	Sell	278,825 -83,000	-23%	-$4.45M	0.03%	335
2015 Q1	$18.1M	Sell	361,825 -68,300	-16%	-$2.87M	0.03%	357
2014 Q4	$14.9M	Sell	430,125 -310,287	-42%	-$10.8M	0.02%	365
2014 Q3	$24.3M	Sell	740,412 -4,800	-0.6%	-$169K	0.03%	309
2014 Q2	$28.6M	Sell	745,212 -199,908	-21%	-$6.98M	0.04%	306
2014 Q1	$37.6M	Sell	945,120 -199,109	-17%	-$8.91M	0.06%	256
2013 Q4	$42.6M	Buy	1,144,229 +719,911	+170%	+$29.9M	0.07%	244
2013 Q3	$19.4M	Buy	+424,318	New	+$12.7M	0.04%	315

Other funds holding KYTH

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Waddell & Reed Financial's KYTH Position: Q3 2015 in Review

Waddell & Reed Financial sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 278,825 shares — an estimated $21M sold.

Waddell & Reed Financial first reported a position in KYTH in Q3 2013 and held it in 8 quarters. The position peaked at $42.6M in Q4 2013. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Waddell & Reed Financial reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Waddell & Reed Financial sold 278,825 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $21M.
Waddell & Reed Financial first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 8 quarters.
Waddell & Reed Financial's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $42.6M in Q4 2013.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Waddell & Reed Financial's 13F filing for Q3 2015, filed 13 Nov 2015.